These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21741841)

  • 1. Muscle atrophy in muscle-specific tyrosine kinase (MuSK)-related myasthenia gravis.
    Moon SY; Lee SS; Hong YH
    J Clin Neurosci; 2011 Sep; 18(9):1274-5. PubMed ID: 21741841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI evidence of early muscle atrophy in MuSK positive myasthenia gravis.
    Zouvelou V; Rentzos M; Toulas P; Evdokimidis I
    J Neuroimaging; 2011 Jul; 21(3):303-5. PubMed ID: 20002967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with patients with anti-MUSK antibody positive myasthenia gravis.
    Sundar U; Shaunbhag P; Lakkas Y; Shrivastava M; Shah A; Vaidya M; Asole D
    J Assoc Physicians India; 2010 Oct; 58():640-2. PubMed ID: 21510119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myopathy, muscle atrophy and tongue lipid composition in MuSK myasthenia gravis.
    Nikolić AV; Bačić GG; Daković MŽ; Lavrnić SĐ; Rakočević Stojanović VM; Basta IZ; Lavrnić DV
    Acta Neurol Belg; 2015 Sep; 115(3):361-5. PubMed ID: 25253293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AchR-positive myasthenia gravis with MRI evidence of early muscle atrophy.
    Zouvelou V; Rentzos M; Toulas P; Evdokimidis I
    J Clin Neurosci; 2012 Jun; 19(6):918-9. PubMed ID: 22341149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against Wnt receptor of muscle-specific tyrosine kinase in myasthenia gravis.
    Takamori M; Nakamura T; Motomura M
    J Neuroimmunol; 2013 Jan; 254(1-2):183-6. PubMed ID: 22999188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
    Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
    Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoidosis in a case of MuSK-positive myasthenia gravis.
    Spengos K; Vassilopoulou S; Christou Y; Manta P
    Neuromuscul Disord; 2008 Nov; 18(11):890-1. PubMed ID: 18815037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis.
    Guptill JT; Sanders DB
    Curr Opin Neurol; 2010 Oct; 23(5):530-5. PubMed ID: 20613516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
    Díaz-Manera J; Rojas-García R; Gallardo E; Juárez C; Martínez-Domeño A; Martínez-Ramírez S; Dalmau J; Blesa R; Illa I
    Nat Clin Pract Neurol; 2007 Jul; 3(7):405-10. PubMed ID: 17611489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis.
    Farrugia ME; Kennett RP; Newsom-Davis J; Hilton-Jones D; Vincent A
    Muscle Nerve; 2006 Apr; 33(4):568-70. PubMed ID: 16382443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.
    Benveniste O; Jacobson L; Farrugia ME; Clover L; Vincent A
    J Neuroimmunol; 2005 Dec; 170(1-2):41-8. PubMed ID: 16213598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.
    Wolfe GI; Oh SJ
    Ann N Y Acad Sci; 2008; 1132():71-5. PubMed ID: 18567855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy.
    Chan JW; Orrison WW
    Br J Ophthalmol; 2007 Jun; 91(6):842-3. PubMed ID: 17510484
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are MuSK antibodies the primary cause of myasthenic symptoms?
    Selcen D; Fukuda T; Shen XM; Engel AG
    Neurology; 2004 Jun; 62(11):1945-50. PubMed ID: 15184594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.